Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$63.75 - $108.06 $7.98 Million - $13.5 Million
125,172 Added 245.92%
176,072 $12.3 Million
Q4 2023

Feb 13, 2024

SELL
$26.88 - $83.49 $9,004 - $27,969
-335 Reduced 0.65%
50,900 $4.25 Million
Q3 2023

Nov 13, 2023

BUY
$29.46 - $36.61 $32,052 - $39,831
1,088 Added 2.17%
51,235 $1.51 Million
Q2 2023

Aug 04, 2023

BUY
$32.62 - $40.75 $147,801 - $184,638
4,531 Added 9.93%
50,147 $1.64 Million
Q1 2023

May 12, 2023

BUY
$33.36 - $45.71 $3,702 - $5,073
111 Added 0.24%
45,616 $1.61 Million
Q4 2022

Feb 10, 2023

SELL
$35.77 - $51.11 $12,447 - $17,786
-348 Reduced 0.76%
45,505 $2.09 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $42,740 - $60,462
1,109 Added 2.48%
45,853 $2.22 Million
Q2 2022

Aug 12, 2022

SELL
$33.93 - $48.92 $34,947 - $50,387
-1,030 Reduced 2.25%
44,744 $1.76 Million
Q1 2022

May 13, 2022

SELL
$29.74 - $46.0 $82,944 - $128,294
-2,789 Reduced 5.74%
45,774 $1.69 Million
Q4 2021

Feb 11, 2022

SELL
$34.35 - $46.38 $52,761 - $71,239
-1,536 Reduced 3.07%
48,563 $2.21 Million
Q3 2021

Nov 12, 2021

BUY
$18.54 - $35.74 $102,897 - $198,357
5,550 Added 12.46%
50,099 $1.79 Million
Q2 2021

Aug 13, 2021

SELL
$19.79 - $26.99 $692 - $944
-35 Reduced 0.08%
44,549 $882,000
Q1 2021

May 07, 2021

SELL
$18.57 - $25.68 $9,526 - $13,173
-513 Reduced 1.14%
44,584 $1.04 Million
Q4 2020

Feb 12, 2021

SELL
$15.26 - $28.61 $16,679 - $31,270
-1,093 Reduced 2.37%
45,097 $937,000
Q3 2020

Nov 04, 2020

BUY
$20.58 - $28.96 $128,974 - $181,492
6,267 Added 15.7%
46,190 $1 Million
Q2 2020

Aug 12, 2020

BUY
$11.15 - $24.64 $14,517 - $32,081
1,302 Added 3.37%
39,923 $941,000
Q1 2020

May 04, 2020

SELL
$8.75 - $16.3 $16,651 - $31,018
-1,903 Reduced 4.7%
38,621 $455,000
Q4 2019

Feb 05, 2020

SELL
$7.95 - $11.84 $8,617 - $12,834
-1,084 Reduced 2.61%
40,524 $430,000
Q3 2019

Nov 08, 2019

BUY
$10.82 - $14.25 $2,304 - $3,035
213 Added 0.51%
41,608 $473,000
Q2 2019

Aug 13, 2019

BUY
$7.95 - $11.25 $44,734 - $63,303
5,627 Added 15.73%
41,395 $466,000
Q1 2019

May 06, 2019

SELL
$5.95 - $10.19 $5,616 - $9,619
-944 Reduced 2.57%
35,768 $289,000
Q4 2018

Feb 13, 2019

SELL
$5.91 - $9.29 $2,641 - $4,152
-447 Reduced 1.2%
36,712 $232,000
Q3 2018

Nov 09, 2018

BUY
$6.4 - $9.85 $7,321 - $11,268
1,144 Added 3.18%
37,159 $366,000
Q2 2018

Aug 08, 2018

BUY
$6.9 - $9.9 $65,267 - $93,644
9,459 Added 35.62%
36,015 $299,000
Q1 2018

May 07, 2018

SELL
$7.2 - $10.05 $54,568 - $76,168
-7,579 Reduced 22.2%
26,556 $191,000
Q4 2017

Feb 09, 2018

BUY
$7.25 - $15.65 $1,152 - $2,488
159 Added 0.47%
34,135 $278,000
Q3 2017

Nov 09, 2017

BUY
$12.0 - $15.0 $407,712 - $509,640
33,976
33,976 $493,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.